Approaching the 12th consecutive year, our goal for BioTrinity is simple – to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape our healthcare future.

Our theme for BioTrinity 2018 is ‘Next Generation Healthcare’ which we will explore via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery’, ‘An insight into Nanotechnology’, ‘Next Generation Chemistry’ and ‘Fintech and the Future of the Investment Industry’ – keep an eye on the conference programme.

BioTrinity offers unique access to investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to strike deals and grow their networks.

BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors. For more information on OBN visit our website.

£300 discount for BioPartner members.

Find out more here